|
Feb 27
|
Novocure Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Company Update
|
|
Feb 20
|
NovoCure (NVCR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
|
Feb 20
|
Luxury hotels group Firmdale has sold 20% stake to Swedish pharma tycoon
|
|
Jan 30
|
Jim Cramer on NovoCure Limited (NVCR): ‘I Have Watched Them For Years And Years And They’re Not Making Money’
|
|
Jan 3
|
Novocure to Participate in 43rd Annual J.P. Morgan Healthcare Conference
|
|
Oct 1
|
Novocure to Report Third Quarter 2024 Financial Results
|
|
Sep 6
|
Why NovoCure Stock Dived by 13% This Week
|
|
Sep 3
|
NovoCure CEO Asaf Danziger to Retire, CFO Ashley Cordova Named Successor
|
|
Sep 3
|
Novocure Announces Planned CEO Transition
|
|
Aug 28
|
Novocure to Participate in 2024 Wells Fargo Healthcare Conference
|
|
Aug 16
|
Wall Street Analysts Think NovoCure (NVCR) Could Surge 35.96%: Read This Before Placing a Bet
|
|
Aug 14
|
Novocure Highlights TTFields Therapy in Treatment of Non-Small Cell Lung Cancer at 2024 World Conference on Lung Cancer
|
|
Aug 12
|
Biotech stocks: Which drugmakers are worth a buy?
|
|
Jul 25
|
NovoCure (NVCR) Q2 2024 Earnings Call Transcript
|
|
Jul 25
|
NovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates
|
|
Jul 25
|
NovoCure: Q2 Earnings Snapshot
|
|
Jul 25
|
Novocure Reports Second Quarter 2024 Financial Results
|
|
May 3
|
NovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript
|
|
May 3
|
NovoCure (NVCR) Q1 2024 Earnings Call Transcript
|
|
May 2
|
NovoCure Ltd (NVCR) Q1 2024 Earnings: Revenue Surpasses Estimates, Narrower Net Loss Reported
|